Navigation Links
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
Date:11/22/2013

ron's products, product candidates, and research and clinical programs now underway or planned, including without limitation sarilumab; unforeseen safety issues resulting from the administration of products and product candidates in patients, including serious complications or side effects in connection with the use of Regeneron's product candidates in clinical trials; the likelihood and timing of possible regulatory approval and commercial launch of Regeneron's late-stage product candidates; ongoing regulatory obligations and oversight impacting Regeneron's research and clinical programs and business; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's products and product candidates; competing drugs and product candidates that may be superior to Regeneron's products and product candidates; uncertainty of market acceptance and commercial success of Regeneron's products and product candidates; the ability of Regeneron to manufacture and manage supply chains for multiple products and product candidates; coverage and reimbursement determinations by third-party payers, including Medicare and Medicaid; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its sales or other financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license or collaboration agreement, including Regeneron's agreements with Sanofi and Bayer HealthCare, to be cancelled or terminated without any further product success; and risks associated with third party intellectual property and pending or future litigation relating thereto.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission, including its Form 10-K for the year ended Decemb
'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Heart Valve Repair and Replacement Market ... About Heart Valve Repair and Replacement Heart ... control the flow of blood during the cardiac ... such as valvular stenosis, valvular insufficiency or regurgitation, ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new market ... Baby Food Eastern Europe 2014 ... 2014" is a new report by ERC that analyzes ... Eastern Europe , key segments, features & developments, ... examines trends which are currently affecting the industry. Furthermore, ...
(Date:8/27/2014)... , Aug. 27, 2014 North American lighting leader ... R&D 100 Award for the new OSRAM ITOS ® ... white light module for microscopy, endoscopy and surgical head lamps ... significantly higher efficacy and lamp life. "We,re honored ... of the most innovative new technologies of the past year," ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
... Aug. 23 Imagenetix, Inc. (OTC Bulletin Board: IAGX ... in July and the first half of August that it expects ... September 30, 2010, to be from $2.8 to $3.2 million, an ... fiscal 2011 and 47% to 68% compared to the second quarter ...
... EXTON, Pa., Aug. 23 Kensey Nash Corporation (Nasdaq: ... regenerative medicine for a wide range of medical procedures, today ... ended June 30, 2010.   Fourth Quarter ... $21.9 million for the quarter, exceeding the high end of ...
Cached Medicine Technology:Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011 2Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 2Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 4Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 5Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 6Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 7Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 8Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 9Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 10Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 11Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 12Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 13Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 14
(Date:8/27/2014)... Three locations will each receive $100,000 in funding to ... and follow-up care for patients served by community health ... Colorectal Cancer Roundtable and is part of the group,s ... adults 50 and over receiving regular screening for colorectal ... a competitive process are: Port Royal, South Carolina; New ...
(Date:8/27/2014)... CarePoint Health is proud to ... has joined our network, CarePoint Health Medical Group. ... Oko, Dr. Yanina Meshko and Dr. Nana Yenukashvili ... experienced physicians comprise CarePoint Health Medical Group, a ... Hudson County, representing a wide range of specialties. ...
(Date:8/27/2014)... returning to school this month will be up to ... Jennifer Reich, a researcher at the University of Colorado ... be fully vaccinated depends on the class privilege of ... Immunization Information, three children per 1000 in the U.S. ... all children receiving vaccines later than recommended. The number ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Dr. Winifred ... , a leader in promoting better health outcomes through ... addition of Ms. Maura Connor to the executive team ... Editor-in-Chief, Ms. Connor will be responsible for providing innovation, ... digital products and content across all markets. , ...
(Date:8/27/2014)... jaundice: It,s one of the last things a parent ... condition in babies less than a week old. , ... that a newborn is jaundiced and isn,t adequately eliminating ... to see, and severe jaundice left untreated can harm ... have developed a smartphone application that checks for jaundice ...
Breaking Medicine News(10 mins):Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 3Health News:Expression of privilege in vaccine refusal 2Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3
... A daytime sleep could have cardiovascular benefits according to new ... College in Pennsylvania in the US. Their study, looking at ... a stress test, found that those participants who slept for ... blood pressure after psychological stress than those who did not ...
... U.S. Department of Energy,s (DOE) Brookhaven National Laboratory reveals a ... overeat, or binge: In binge eaters but not ordinary obese ... a spike in dopamine - a brain chemical linked to ... 24, 2011, in the journal Obesity - suggest ...
... The University of Miami,s College of Arts and ... awarded a Howard Hughes Medical Institute grant to ... in response to the 2009 American Association of ... Future Physicians (SFFP)" report. The grant will ...
... scientists from the Swedish medical university Karolinska Institutet. A new ... that free radicals act as signal substances that cause the ... are molecules that react readily with other substances in the ... certain circumstances, through the damage caused to cells. Free radicals ...
... , SUNDAY, Feb. 27 (HealthDay News) -- A ... initially thought to dramatically cut the risk of several major ... of vitamin D by adults in the range of 4,000-8,000 ... metabolites in the range needed to reduce by about half ...
... BOSTON, Feb. 28, 2011 A gel developed to protect ... when used in the rectum, according to an early-phase study ... Infections (CROI). The results, based on rectal tissue biopsies sampled ... for one week, provide the first-ever evidence that tenofovir gel ...
Cached Medicine News:Health News:Blood pressure management: Sleep on it 2Health News:Binge eaters' dopamine levels spike at sight, smell of food 2Health News:Binge eaters' dopamine levels spike at sight, smell of food 3Health News:University of Miami awarded Howard Hughes Medical Institute experiment grant 2Health News:Free radicals may be good for you 2Health News: Higher Vitamin D Intake Could Cut Cancer Risk 2Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 2Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 3Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 4
Standard Deflectable Catheters...
Standard Deflectable Catheters...
... wide range of fixed curve catheters designed ... children and other patients with small anatomies. ... using only the finest materials. A unique ... and extrusion technologies results in the excellent ...
... offers a wide range of fixed curve ... needs of children and other patients with ... demanding specifications using only the finest materials. ... wire braiding and extrusion technologies results in ...
Medicine Products: